ABION Inc. (KOSDAQ:203400)
South Korea · Delayed Price · Currency is KRW 1,763.00
-156.00 (-8.13%)
At close: Jun 5, 2026
ABION Market Cap
ABION has a market cap or net worth of 158.85 billion as of June 5, 2026. Its market cap has decreased by -8.16% in one year.
Market Cap
158.85B
Enterprise Value
149.79B
Revenue
1.01B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,763.00
Market Cap Chart
Since April 5, 2017, ABION's market cap has increased from 54.88B to 158.85B, an increase of 189.43%. That is a compound annual growth rate of 12.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 158.85B | -43.67% |
| Dec 30, 2025 | 282.02B | 40.69% |
| Dec 30, 2024 | 200.46B | 22.52% |
| Dec 28, 2023 | 163.61B | 29.00% |
| Dec 29, 2022 | 126.83B | -53.68% |
| Dec 30, 2021 | 273.81B | 220.25% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Y-Biologics | 225.39B |
| NIBEC | 221.56B |
| Genome & Company | 195.98B |
| ViGenCell | 194.74B |
| TiumBio | 186.54B |
| Bio Solution | 180.37B |
| Ensol Biosciences | 172.98B |
| Prestige Biologics | 142.13B |